Relationship between loperamide-induced sedative effect and digoxin pharmacokinetics in healthy Japanese subjects

Michiya Kobayashi, Hiroshi Saitoh, Michiko Yamaguchi, Takeshi Saito, Hiroyoshi Fujita, Manabu Suno, Kazuo Matsubara, Bruce J. Aungst

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Purpose. Loperamide-induced suppressive effects on central nervous system closely relate to a lack of or decline in the P-glycoprotein (P-gp) function. The aim of this study was to determine the loperamide-induced sedative effect quantitatively and to investigate possible alterations in the pharmacokinetics of digoxin, a substrate for P-gp, in Japanese subjects. Methods. Loperamide hydrochloride (2 mg) was administered orally to 26 subjects and the critical flicker-fusion frequency threshold (CFF) values were measured every 30 min separately by portable instrument. Further, digoxin (0.25 mg) was administered to 8 subjects, and the plasma concentration was determined. Results. In five subjects who complained of drowsiness, the CFF values more remarkably decreased compared with those in the other subjects. The Tmax and mean residence time (MRT) values of digoxin pharmacokinetics in four subjects with drowsiness were significantly lower and Cmax was higher than those in four subjects with marginal effect. Moreover, there were good correlations between the CFF value-time profile and the Cmax, Tmax, and MRT of digoxin. Conclusions. The determination of the CFF value after oral administration of loperamide will be useful for evaluating varied P-gp function and for anticipating individual variations in the disposition of P-gp substrates in humans.

Original languageEnglish
Pages (from-to)413-418
Number of pages6
JournalPharmaceutical Research
Volume22
Issue number3
DOIs
Publication statusPublished - Mar 2005
Externally publishedYes

Fingerprint

Flicker Fusion
Loperamide
Pharmacokinetics
Digoxin
P-Glycoprotein
Hypnotics and Sedatives
Healthy Volunteers
Fusion reactions
Sleep Stages
Neurology
Substrates
Oral Administration
Central Nervous System
Plasmas

Keywords

  • Digoxin
  • Individual variations
  • Loperamide
  • P-glycoprotein
  • Polymorphism

ASJC Scopus subject areas

  • Chemistry(all)
  • Pharmaceutical Science
  • Pharmacology

Cite this

Relationship between loperamide-induced sedative effect and digoxin pharmacokinetics in healthy Japanese subjects. / Kobayashi, Michiya; Saitoh, Hiroshi; Yamaguchi, Michiko; Saito, Takeshi; Fujita, Hiroyoshi; Suno, Manabu; Matsubara, Kazuo; Aungst, Bruce J.

In: Pharmaceutical Research, Vol. 22, No. 3, 03.2005, p. 413-418.

Research output: Contribution to journalArticle

Kobayashi, M, Saitoh, H, Yamaguchi, M, Saito, T, Fujita, H, Suno, M, Matsubara, K & Aungst, BJ 2005, 'Relationship between loperamide-induced sedative effect and digoxin pharmacokinetics in healthy Japanese subjects', Pharmaceutical Research, vol. 22, no. 3, pp. 413-418. https://doi.org/10.1007/s11095-004-1879-6
Kobayashi, Michiya ; Saitoh, Hiroshi ; Yamaguchi, Michiko ; Saito, Takeshi ; Fujita, Hiroyoshi ; Suno, Manabu ; Matsubara, Kazuo ; Aungst, Bruce J. / Relationship between loperamide-induced sedative effect and digoxin pharmacokinetics in healthy Japanese subjects. In: Pharmaceutical Research. 2005 ; Vol. 22, No. 3. pp. 413-418.
@article{d9682f3039734770a39de39932ebaa1e,
title = "Relationship between loperamide-induced sedative effect and digoxin pharmacokinetics in healthy Japanese subjects",
abstract = "Purpose. Loperamide-induced suppressive effects on central nervous system closely relate to a lack of or decline in the P-glycoprotein (P-gp) function. The aim of this study was to determine the loperamide-induced sedative effect quantitatively and to investigate possible alterations in the pharmacokinetics of digoxin, a substrate for P-gp, in Japanese subjects. Methods. Loperamide hydrochloride (2 mg) was administered orally to 26 subjects and the critical flicker-fusion frequency threshold (CFF) values were measured every 30 min separately by portable instrument. Further, digoxin (0.25 mg) was administered to 8 subjects, and the plasma concentration was determined. Results. In five subjects who complained of drowsiness, the CFF values more remarkably decreased compared with those in the other subjects. The Tmax and mean residence time (MRT) values of digoxin pharmacokinetics in four subjects with drowsiness were significantly lower and Cmax was higher than those in four subjects with marginal effect. Moreover, there were good correlations between the CFF value-time profile and the Cmax, Tmax, and MRT of digoxin. Conclusions. The determination of the CFF value after oral administration of loperamide will be useful for evaluating varied P-gp function and for anticipating individual variations in the disposition of P-gp substrates in humans.",
keywords = "Digoxin, Individual variations, Loperamide, P-glycoprotein, Polymorphism",
author = "Michiya Kobayashi and Hiroshi Saitoh and Michiko Yamaguchi and Takeshi Saito and Hiroyoshi Fujita and Manabu Suno and Kazuo Matsubara and Aungst, {Bruce J.}",
year = "2005",
month = "3",
doi = "10.1007/s11095-004-1879-6",
language = "English",
volume = "22",
pages = "413--418",
journal = "Pharmaceutical Research",
issn = "0724-8741",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Relationship between loperamide-induced sedative effect and digoxin pharmacokinetics in healthy Japanese subjects

AU - Kobayashi, Michiya

AU - Saitoh, Hiroshi

AU - Yamaguchi, Michiko

AU - Saito, Takeshi

AU - Fujita, Hiroyoshi

AU - Suno, Manabu

AU - Matsubara, Kazuo

AU - Aungst, Bruce J.

PY - 2005/3

Y1 - 2005/3

N2 - Purpose. Loperamide-induced suppressive effects on central nervous system closely relate to a lack of or decline in the P-glycoprotein (P-gp) function. The aim of this study was to determine the loperamide-induced sedative effect quantitatively and to investigate possible alterations in the pharmacokinetics of digoxin, a substrate for P-gp, in Japanese subjects. Methods. Loperamide hydrochloride (2 mg) was administered orally to 26 subjects and the critical flicker-fusion frequency threshold (CFF) values were measured every 30 min separately by portable instrument. Further, digoxin (0.25 mg) was administered to 8 subjects, and the plasma concentration was determined. Results. In five subjects who complained of drowsiness, the CFF values more remarkably decreased compared with those in the other subjects. The Tmax and mean residence time (MRT) values of digoxin pharmacokinetics in four subjects with drowsiness were significantly lower and Cmax was higher than those in four subjects with marginal effect. Moreover, there were good correlations between the CFF value-time profile and the Cmax, Tmax, and MRT of digoxin. Conclusions. The determination of the CFF value after oral administration of loperamide will be useful for evaluating varied P-gp function and for anticipating individual variations in the disposition of P-gp substrates in humans.

AB - Purpose. Loperamide-induced suppressive effects on central nervous system closely relate to a lack of or decline in the P-glycoprotein (P-gp) function. The aim of this study was to determine the loperamide-induced sedative effect quantitatively and to investigate possible alterations in the pharmacokinetics of digoxin, a substrate for P-gp, in Japanese subjects. Methods. Loperamide hydrochloride (2 mg) was administered orally to 26 subjects and the critical flicker-fusion frequency threshold (CFF) values were measured every 30 min separately by portable instrument. Further, digoxin (0.25 mg) was administered to 8 subjects, and the plasma concentration was determined. Results. In five subjects who complained of drowsiness, the CFF values more remarkably decreased compared with those in the other subjects. The Tmax and mean residence time (MRT) values of digoxin pharmacokinetics in four subjects with drowsiness were significantly lower and Cmax was higher than those in four subjects with marginal effect. Moreover, there were good correlations between the CFF value-time profile and the Cmax, Tmax, and MRT of digoxin. Conclusions. The determination of the CFF value after oral administration of loperamide will be useful for evaluating varied P-gp function and for anticipating individual variations in the disposition of P-gp substrates in humans.

KW - Digoxin

KW - Individual variations

KW - Loperamide

KW - P-glycoprotein

KW - Polymorphism

UR - http://www.scopus.com/inward/record.url?scp=17644386177&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17644386177&partnerID=8YFLogxK

U2 - 10.1007/s11095-004-1879-6

DO - 10.1007/s11095-004-1879-6

M3 - Article

VL - 22

SP - 413

EP - 418

JO - Pharmaceutical Research

JF - Pharmaceutical Research

SN - 0724-8741

IS - 3

ER -